180 related articles for article (PubMed ID: 34584216)
1. Mutant collagen COL11A1 enhances cancerous invasion.
Lee CS; Siprashvili Z; Mah A; Bencomo T; Elcavage LE; Che Y; Shenoy RM; Aasi SZ; Khavari PA
Oncogene; 2021 Nov; 40(44):6299-6307. PubMed ID: 34584216
[TBL] [Abstract][Full Text] [Related]
2. Collagen XI regulates the acquisition of collagen fibril structure, organization and functional properties in tendon.
Sun M; Luo EY; Adams SM; Adams T; Ye Y; Shetye SS; Soslowsky LJ; Birk DE
Matrix Biol; 2020 Dec; 94():77-94. PubMed ID: 32950601
[TBL] [Abstract][Full Text] [Related]
3. COL11A1/(pro)collagen 11A1 expression is a remarkable biomarker of human invasive carcinoma-associated stromal cells and carcinoma progression.
Vázquez-Villa F; García-Ocaña M; Galván JA; García-Martínez J; García-Pravia C; Menéndez-Rodríguez P; González-del Rey C; Barneo-Serra L; de Los Toyos JR
Tumour Biol; 2015 Apr; 36(4):2213-22. PubMed ID: 25761876
[TBL] [Abstract][Full Text] [Related]
4. A novel dominant COL11A1 mutation resulting in a severe skeletal dysplasia.
Hufnagel SB; Weaver KN; Hufnagel RB; Bader PI; Schorry EK; Hopkin RJ
Am J Med Genet A; 2014 Oct; 164A(10):2607-12. PubMed ID: 25091507
[TBL] [Abstract][Full Text] [Related]
5. The intercellular expression of type-XVII collagen, laminin-332, and integrin-β1 promote contact following during the collective invasion of a cancer cell population.
Kumagai Y; Nio-Kobayashi J; Ishida-Ishihara S; Tachibana H; Omori R; Enomoto A; Ishihara S; Haga H
Biochem Biophys Res Commun; 2019 Jul; 514(4):1115-1121. PubMed ID: 31101337
[TBL] [Abstract][Full Text] [Related]
6. COL11A1 promotes tumor progression and predicts poor clinical outcome in ovarian cancer.
Wu YH; Chang TH; Huang YF; Huang HD; Chou CY
Oncogene; 2014 Jun; 33(26):3432-40. PubMed ID: 23934190
[TBL] [Abstract][Full Text] [Related]
7. Collagens XV and XVIII show different expression and localisation in cutaneous squamous cell carcinoma: type XV appears in tumor stroma, while XVIII becomes upregulated in tumor cells and lost from microvessels.
Karppinen SM; Honkanen HK; Heljasvaara R; Riihilä P; Autio-Harmainen H; Sormunen R; Harjunen V; Väisänen MR; Väisänen T; Hurskainen T; Tasanen K; Kähäri VM; Pihlajaniemi T
Exp Dermatol; 2016 May; 25(5):348-54. PubMed ID: 26660139
[TBL] [Abstract][Full Text] [Related]
8. COL11A1 is overexpressed in recurrent non-small cell lung cancer and promotes cell proliferation, migration, invasion and drug resistance.
Shen L; Yang M; Lin Q; Zhang Z; Zhu B; Miao C
Oncol Rep; 2016 Aug; 36(2):877-85. PubMed ID: 27373316
[TBL] [Abstract][Full Text] [Related]
9. Transmembrane collagen XVII modulates integrin dependent keratinocyte migration via PI3K/Rac1 signaling.
Löffek S; Hurskainen T; Jackow J; Sigloch FC; Schilling O; Tasanen K; Bruckner-Tuderman L; Franzke CW
PLoS One; 2014; 9(2):e87263. PubMed ID: 24505282
[TBL] [Abstract][Full Text] [Related]
10. Regulation of collagen fibril nucleation and initial fibril assembly involves coordinate interactions with collagens V and XI in developing tendon.
Wenstrup RJ; Smith SM; Florer JB; Zhang G; Beason DP; Seegmiller RE; Soslowsky LJ; Birk DE
J Biol Chem; 2011 Jun; 286(23):20455-65. PubMed ID: 21467034
[TBL] [Abstract][Full Text] [Related]
11. Novel pathogenic COL11A1/COL11A2 variants in Stickler syndrome detected by targeted NGS and exome sequencing.
Acke FR; Malfait F; Vanakker OM; Steyaert W; De Leeneer K; Mortier G; Dhooge I; De Paepe A; De Leenheer EM; Coucke PJ
Mol Genet Metab; 2014 Nov; 113(3):230-5. PubMed ID: 25240749
[TBL] [Abstract][Full Text] [Related]
12. Identification of genetic mutations of cutaneous squamous cell carcinoma using whole exome sequencing in non-Caucasian population.
Lee SY; Lee M; Yu DS; Lee YB
J Dermatol Sci; 2022 May; 106(2):70-77. PubMed ID: 35365379
[TBL] [Abstract][Full Text] [Related]
13. Fibrochondrogenesis results from mutations in the COL11A1 type XI collagen gene.
Tompson SW; Bacino CA; Safina NP; Bober MB; Proud VK; Funari T; Wangler MF; Nevarez L; Ala-Kokko L; Wilcox WR; Eyre DR; Krakow D; Cohn DH
Am J Hum Genet; 2010 Nov; 87(5):708-12. PubMed ID: 21035103
[TBL] [Abstract][Full Text] [Related]
14. Differential mutation frequencies in metastatic cutaneous squamous cell carcinomas versus primary tumors.
Yilmaz AS; Ozer HG; Gillespie JL; Allain DC; Bernhardt MN; Furlan KC; Castro LT; Peters SB; Nagarajan P; Kang SY; Iwenofu OH; Olencki T; Teknos TN; Toland AE
Cancer; 2017 Apr; 123(7):1184-1193. PubMed ID: 27906449
[TBL] [Abstract][Full Text] [Related]
15. Alternative splicing modifies the effect of mutations in COL11A1 and results in recessive type 2 Stickler syndrome with profound hearing loss.
Richards AJ; Fincham GS; McNinch A; Hill D; Poulson AV; Castle B; Lees MM; Moore AT; Scott JD; Snead MP
J Med Genet; 2013 Nov; 50(11):765-71. PubMed ID: 23922384
[TBL] [Abstract][Full Text] [Related]
16. Col11a1 and Col11a2 mRNA expression in the developing mouse cochlea: implications for the correlation of hearing loss phenotype with mutant type XI collagen genotype.
Shpargel KB; Makishima T; Griffith AJ
Acta Otolaryngol; 2004 Apr; 124(3):242-8. PubMed ID: 15141750
[TBL] [Abstract][Full Text] [Related]
17. Development of novel real-time RT-qPCR methodologies for quantification of the COL11A1 mRNA general and C transcripts and evaluation in non-small cell lung cancer specimens.
Rizou T; Perlikos F; Lagiou M; Karaglani M; Nikolopoulos S; Toumpoulis I; Kroupis C
J BUON; 2018; 23(6):1699-1710. PubMed ID: 30610797
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-125b down-regulates matrix metallopeptidase 13 and inhibits cutaneous squamous cell carcinoma cell proliferation, migration, and invasion.
Xu N; Zhang L; Meisgen F; Harada M; Heilborn J; Homey B; Grandér D; Ståhle M; Sonkoly E; Pivarcsi A
J Biol Chem; 2012 Aug; 287(35):29899-908. PubMed ID: 22782903
[TBL] [Abstract][Full Text] [Related]
19. H-Ras activation and fibroblast-induced TGF-β signaling promote laminin-332 accumulation and invasion in cutaneous squamous cell carcinoma.
Siljamäki E; Rappu P; Riihilä P; Nissinen L; Kähäri VM; Heino J
Matrix Biol; 2020 May; 87():26-47. PubMed ID: 31655292
[TBL] [Abstract][Full Text] [Related]
20. Complement factor I upregulates expression of matrix metalloproteinase-13 and -2 and promotes invasion of cutaneous squamous carcinoma cells.
Rahmati Nezhad P; Riihilä P; Piipponen M; Kallajoki M; Meri S; Nissinen L; Kähäri VM
Exp Dermatol; 2021 Nov; 30(11):1631-1641. PubMed ID: 33813765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
